 Clinical Decision Support to Enable Precision Oncology FT. MYERS, FL ACCESSWIRE March 24, 2021 NeoGenomics, Inc. NASDAQ:NEO, a leading provider of cancer-focused genetic testing services and global oncology contract research services, announced today that it has agreed to acquire Intervention Insights, Inc. dba Trapelo Health, an Information Technology company focused on precision oncology. 